pSivida and Nicox inks deal to develop sustained release drug to lower IOP in patients with Glaucoma; shares ahead 12% premarket [Seeking Alpha]
PSIVIDA (PSDV)
Last psivida earnings: 2/7 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.psivida.com
Company Research
Source: Seeking Alpha
pSivida and Nicox inks deal to develop sustained release drug to lower IOP in patients with Glaucoma; shares ahead 12% premarketpSivida (NASDAQ:PSDV) and Nicox S.A. (OTCPK:NICXF)collaborate to explore the potential of combining pSivida's bioerodible sustained release drug delivery system with Nicox's nitric oxide-donating compounds, to develop a sustained release drug to lower intraocular pressure in patients with glaucoma or ocular hypertension.pSivida will be responsible for initial development activities of ocular insert formulations, for which it will receive undisclosed sums by Nicox.Nicox would make additional payments for any incremental development activities. New intellectual property from the collaboration will be jointly owned. Separate license agreement will be negotiated for any product candidate, developed and commercialize as a result of this collaboration.Shares of pSivida are ahead12% premarket on modest volume.Now read:uniQure: A Busted Biotech IPO Worth Owning »
Show less
Read more
Impact Snapshot
Event Time:
PSDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSDV alerts
High impacting PSIVIDA news events
Weekly update
A roundup of the hottest topics